The Latest Updates in Longevity Research with Dr. Eric Verdin

The content of this podcast episode was automatically imported from the publicly available RSS feed provided by the creator of the podcast.

Episode release date
Episode length
01:06:04

Episode shownotes

This episode of Longevity by Design features an interview with Dr. Eric Verdin—the CEO of The Buck Institute. The Buck Institute was the first center dedicated to aging research, and many discoveries within the aging field have come out of this research center. 

For this episode, Dr. Verdin, Dr. Blander, and Ashely Reaver sat down in person to discuss the latest updates in longevity research. Dr. Verdin shares his opinion on questions like “is aging a disease?” and “is there a maximum lifespan that humans will never surpass?” Dr. Verdin also discusses updates on the future of anti-aging drugs, including senolytics and metformin. 

To close the episode, Dr. Verdin gives life advice for what 5 things we can do on a regular basis to improve our health span.

Listen to all episodes of Longevity by Design at https://info.insidetracker.com/longevitybydesign 

Episode timestamps: 

  • Introduction: (0:00–2:40) 
  • About the Buck Institute (2:40–8:00)
  • Biological aging clocks (8:00–14:31)
  • Public opinion and funding aging research (14:31–16:38) 
  • Is aging a disease? (16:38–19:35) 
  • Future of anti-aging drugs (19:35–25:25) 
  • Senescence and senolytics (25:25–29:42) 
  • The hallmarks of aging are interconnected (29:42–36:48) 
  • How medicine and public policy has improved life expectancy (36:48–40:50) 
  • How much of longevity is due to genetics? (40:50–44:52) 
  • Geographic location impacts life expectancy (44:52–51:08) 
  • Is there a maximum lifespan for humans? (51:08–56:40) 
  • Healthspan vs lifespan (56:40–60:04) 
  • The most important interventions to improve healthspan (60:04–1:06:04)